-
Je něco špatně v tomto záznamu ?
HPLC-MS/MS measurement of lidocaine in rat skin and plasma. Application to study the release from medicated plaster
C. Matteo, G. Dovrtelova, A. Di Clemente, R. Frapolli, A. Passoni, T. Ceruti, G. Marsella, L. Cervo, M. Zucchetti,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
- MeSH
- krysa rodu rattus MeSH
- kůže chemie MeSH
- lidokain aplikace a dávkování analýza farmakokinetika MeSH
- limita detekce MeSH
- lineární modely MeSH
- reprodukovatelnost výsledků MeSH
- stabilita léku MeSH
- tandemová hmotnostní spektrometrie metody MeSH
- transdermální náplast * MeSH
- vysokoúčinná kapalinová chromatografie metody MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
A simple, sensitive HPLC-MS/MS method was developed and validated for the determination of lidocaine in skin and plasma of rats. The methods were established and validated assessing lower limit of quantitation (LLOQ), linearity, intra and inter-day precision and accuracy, selectivity, recovery and matrix effect. Chromatography was done on a Gemini column embedded with C18 stationary phase (50 mm × 2.0 mm, 5 µm particle size), using a gradient with mobile phases consisting of 0.1% HCOOH in bidistilled water and 0.1% HCOOH in acetonitrile. The mass spectrometer worked with electrospray ionization in positive ion mode and selected reaction monitoring, using target ions m/z 235.10 for lidocaine and m/z 245.10 for lidocaine-d10, used as internal standard. RESULTS: The linearity of the method was in the ranges of lidocaine concentrations 10.0-200.0 ng/mL for skin homogenate (accuracy 94.1-105.5%; R2 ≥ 0.998) and 0.025-2 ng/mL for plasma (accuracy 96.2-104.8%; R2 ≥ 0.996). The intra- and inter-day precision and accuracy determined on three quality control samples (20, 75 and 170 ng/mL for skin and 0.075, 0.4 and 1.5 ng/mL for plasma) were ≤4.2% and 103.8-108.2% for skin and ≤12.4% and 95.5-101.4% for plasma. The LLOQ was 10 ng/mL in skin homogenate and 0.025 ng/mL in plasma. The applicability of the method was demonstrated by measuring lidocaine in skin and plasma after exposure to medicated patches containing 5% lidocaine.
Animal Care Unit Istituto di Ricerche Farmacologiche Mario Negri IRCCS Milan Italy
Department of Neuroscience Istituto di Ricerche Farmacologiche Mario Negri IRCCS Milan Italy
Department of Oncology Istituto di Ricerche Farmacologiche Mario Negri IRCCS Milan Italy
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20005583
- 003
- CZ-PrNML
- 005
- 20200527082451.0
- 007
- ta
- 008
- 200511s2020 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jchromb.2019.121942 $2 doi
- 035 __
- $a (PubMed)31918305
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Matteo, C $u Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
- 245 10
- $a HPLC-MS/MS measurement of lidocaine in rat skin and plasma. Application to study the release from medicated plaster / $c C. Matteo, G. Dovrtelova, A. Di Clemente, R. Frapolli, A. Passoni, T. Ceruti, G. Marsella, L. Cervo, M. Zucchetti,
- 520 9_
- $a A simple, sensitive HPLC-MS/MS method was developed and validated for the determination of lidocaine in skin and plasma of rats. The methods were established and validated assessing lower limit of quantitation (LLOQ), linearity, intra and inter-day precision and accuracy, selectivity, recovery and matrix effect. Chromatography was done on a Gemini column embedded with C18 stationary phase (50 mm × 2.0 mm, 5 µm particle size), using a gradient with mobile phases consisting of 0.1% HCOOH in bidistilled water and 0.1% HCOOH in acetonitrile. The mass spectrometer worked with electrospray ionization in positive ion mode and selected reaction monitoring, using target ions m/z 235.10 for lidocaine and m/z 245.10 for lidocaine-d10, used as internal standard. RESULTS: The linearity of the method was in the ranges of lidocaine concentrations 10.0-200.0 ng/mL for skin homogenate (accuracy 94.1-105.5%; R2 ≥ 0.998) and 0.025-2 ng/mL for plasma (accuracy 96.2-104.8%; R2 ≥ 0.996). The intra- and inter-day precision and accuracy determined on three quality control samples (20, 75 and 170 ng/mL for skin and 0.075, 0.4 and 1.5 ng/mL for plasma) were ≤4.2% and 103.8-108.2% for skin and ≤12.4% and 95.5-101.4% for plasma. The LLOQ was 10 ng/mL in skin homogenate and 0.025 ng/mL in plasma. The applicability of the method was demonstrated by measuring lidocaine in skin and plasma after exposure to medicated patches containing 5% lidocaine.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a vysokoúčinná kapalinová chromatografie $x metody $7 D002851
- 650 _2
- $a stabilita léku $7 D004355
- 650 _2
- $a lidokain $x aplikace a dávkování $x analýza $x farmakokinetika $7 D008012
- 650 _2
- $a limita detekce $7 D057230
- 650 _2
- $a lineární modely $7 D016014
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a reprodukovatelnost výsledků $7 D015203
- 650 _2
- $a kůže $x chemie $7 D012867
- 650 _2
- $a tandemová hmotnostní spektrometrie $x metody $7 D053719
- 650 12
- $a transdermální náplast $7 D057968
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Dovrtelova, G $u Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy; Department of Pharmacology, Faculty of Medicine, RECETOX Centre, Faculty of Science, Masaryk University and International Clinical Research Center, St. Anne's University Hospital Brno, Czech Republic.
- 700 1_
- $a Di Clemente, A $u Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
- 700 1_
- $a Frapolli, R $u Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
- 700 1_
- $a Passoni, A $u Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
- 700 1_
- $a Ceruti, T $u Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
- 700 1_
- $a Marsella, G $u Animal Care Unit, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
- 700 1_
- $a Cervo, L $u Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
- 700 1_
- $a Zucchetti, M $u Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy. Electronic address: massimo.zucchetti@marionegri.it.
- 773 0_
- $w MED00006642 $t Journal of chromatography. B, Analytical technologies in the biomedical and life sciences $x 1873-376X $g Roč. 1138, č. - (2020), s. 121942
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31918305 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200511 $b ABA008
- 991 __
- $a 20200527082448 $b ABA008
- 999 __
- $a ok $b bmc $g 1524441 $s 1095639
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 1138 $c - $d 121942 $e 20191218 $i 1873-376X $m Journal of chromatography. B, Analytical technologies in the biomedical and life sciences $n J Chromatogr B Analyt Technol Biomed Life Sci $x MED00006642
- LZP __
- $a Pubmed-20200511